-
Cabergoline Trial to Test Breast Cancer Prevention in Postpartum BRCA1 Carriers
Clinical Research News | A multinational, placebo-controlled phase 2 trial will test whether cabergoline, an inexpensive, off-patent drug that suppresses lactation, can lower breast cancer risk in young women who carry BRCA1 pathogenic variants. The idea is to give the drug once these women have decided to wean.
Nov 19, 2026
-
Oracle Launches AI Agents for Clinical Trial Teams
Clinical Research News | Oracle today announced Oracle Life Sciences AI Agents for clinical trial operations. By bringing together insights from Oracle Life Sciences applications and supported third-party data sources, the agents are designed to help clinical trial teams identify operational issues, recommend appropriate actions for review and approval, and coordinate responses across clinical development workflows.
Nov 18, 2026
-
Faster Trial Starts Need A Site Readiness Receipt
Clinical Research News | Clinical research teams have spent years trying to shorten the wait between a promising therapeutic idea and the first participant visit. When those efforts succeed, they will create a different bottleneck: sites asked to move faster through screening, documentation, and activation with no additional room for ambiguity. I would like sponsors to start measuring one thing before celebrating an accelerated timeline: whether the site can explain and correct the critical decisions made along the way.
Nov 17, 2026
-
Wellness Wearables Face a Higher Bar for Supporting Evidence, Experts Say
Clinical Research News | As consumer health wearables move closer to medical territory, product makers need clinical data that supports their claims, whether or not they plan to seek FDA clearance, according to regulatory and clinical research experts at DCN Dx.
Nov 12, 2026
-
Last-Mile Hurdles in Putting AI into Real-World Clinical Research
Clinical Research News | Implementing an artificial intelligence (AI) policy at the highest levels of a clinical research organization requires middle managers empowered and equipped to carry it out companywide. But not every AI workflow deserves the same level of scrutiny, according to Marc Wartenberger, vice president of compliance and security at CRIO, who moderated a panel discussion on the policy-to-practice issues at the recent SCOPE Europe event in Barcelona.
Nov 10, 2026
-
Has Detailing AI’s Reasoning Become Confused With The Tech’s Safety in a PV Context?
Clinical Research News | For any life sciences organization keen to establish appropriate guardrails around their AI use, recent debate about preventing AI’s potential harms has helped frame some of the critical parameters. Previously, too much of the “trusted AI” discussion has centered on the ability to explain how AI has arrived at its conclusions. But this quality alone does not make for robust governance, especially where patient safety is at stake.
Nov 6, 2026
-
Flatiron Building ‘Continuous Intelligence Engine’ for Cancer Research
Clinical Research News | Flatiron Health is building a global oncology intelligence engine that is poised to change how research gets done by scaling data collection and speeding up how researchers extract evidence. The platform, known as Flatiron Telescope, is designed to enable anyone working in oncology to answer questions faster at any stage of drug development.
Nov 5, 2026


